Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Ductal carcinoma in situ with microinvasion: prognostic implications, long-term outcomes, and role of axillary evaluation.

Parikh RR, Haffty BG, Lannin D, Moran MS.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):7-13. doi: 10.1016/j.ijrobp.2010.08.027. Epub 2010 Oct 13.

PMID:
20950955
2.

Ductal carcinoma in situ: value of sentinel lymph node biopsy.

Sakr R, Barranger E, Antoine M, Prugnolle H, Daraï E, Uzan S.

J Surg Oncol. 2006 Oct 1;94(5):426-30. Review.

PMID:
16967457
3.

Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.

Moore KH, Sweeney KJ, Wilson ME, Goldberg JI, Buchanan CL, Tan LK, Liberman L, Turner RR, Lagios MD, Cody Iii HS, Giuliano AE, Silverstein MJ, Van Zee KJ.

Ann Surg Oncol. 2007 Oct;14(10):2911-7. Epub 2007 Jun 28.

PMID:
17597346
4.

Outcome of patients with ductal carcinoma in situ and sentinel node biopsy.

Meretoja TJ, Heikkilä PS, Salmenkivi K, Leidenius MH.

Ann Surg Oncol. 2012 Jul;19(7):2345-51. doi: 10.1245/s10434-012-2287-5. Epub 2012 Mar 7.

PMID:
22395995
5.

Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion?

Klauber-DeMore N, Tan LK, Liberman L, Kaptain S, Fey J, Borgen P, Heerdt A, Montgomery L, Paglia M, Petrek JA, Cody HS, Van Zee KJ.

Ann Surg Oncol. 2000 Oct;7(9):636-42.

PMID:
11034239
6.

Tumor size as predictor of microinvasion, invasion, and axillary metastasis in ductal carcinoma in situ.

Maffuz A, Barroso-Bravo S, Nájera I, Zarco G, Alvarado-Cabrero I, Rodríguez-Cuevas SA.

J Exp Clin Cancer Res. 2006 Jun;25(2):223-7.

PMID:
16918134
7.

An update of sentinel lymph node mapping in patients with ductal carcinoma in situ.

Wilkie C, White L, Dupont E, Cantor A, Cox CE.

Am J Surg. 2005 Oct;190(4):563-6.

PMID:
16164920
8.

259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.

Di Saverio S, Catena F, Santini D, Ansaloni L, Fogacci T, Mignani S, Leone A, Gazzotti F, Gagliardi S, De Cataldis A, Taffurelli M.

Breast Cancer Res Treat. 2008 Jun;109(3):405-16. Epub 2007 Aug 9. Review.

PMID:
17687650
9.

Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS?

Cox CE, Nguyen K, Gray RJ, Salud C, Ku NN, Dupont E, Hutson L, Peltz E, Whitehead G, Reintgen D, Cantor A.

Am Surg. 2001 Jun;67(6):513-9; discussion 519-21.

PMID:
11409797
10.

Breast ductal carcinoma in situ with microinvasion: a definition supported by a long-term study of 1248 serially sectioned ductal carcinomas.

de Mascarel I, MacGrogan G, Mathoulin-Pélissier S, Soubeyran I, Picot V, Coindre JM.

Cancer. 2002 Apr 15;94(8):2134-42.

11.

Outcomes in women treated with MammoSite brachytherapy or whole breast irradiation stratified by ASTRO Accelerated Partial Breast Irradiation Consensus Statement Groups.

Zauls AJ, Watkins JM, Wahlquist AE, Brackett NC 3rd, Aguero EG, Baker MK, Jenrette JM, Garrett-Mayer E, Harper JL.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):21-9. doi: 10.1016/j.ijrobp.2010.08.034. Epub 2010 Oct 15.

PMID:
20951508
12.

Do sentinel node micrometastases predict recurrence risk in ductal carcinoma in situ and ductal carcinoma in situ with microinvasion?

Murphy CD, Jones JL, Javid SH, Michaelson JS, Nolan ME, Lipsitz SR, Specht MC, Lesnikoski BA, Hughes KS, Gadd MA, Smith BL.

Am J Surg. 2008 Oct;196(4):566-8. doi: 10.1016/j.amjsurg.2008.06.011. Epub 2008 Aug 29.

PMID:
18760400
13.

The clinical features and management of women with ductal carcinoma in situ with microinvasion: A retrospective Cohort study.

Li Y, Zhang S, Wei X, Zhang J.

Int J Surg. 2015 Jul;19:91-4. doi: 10.1016/j.ijsu.2015.05.013. Epub 2015 May 23.

PMID:
26013173
14.

Ductal carcinoma in situ with microinvasion.

Adamovich TL, Simmons RM.

Am J Surg. 2003 Aug;186(2):112-6. Review.

PMID:
12885600
15.

Microinvasive breast cancer and the role of sentinel node biopsy: an institutional experience and review of the literature.

Guth AA, Mercado C, Roses DF, Darvishian F, Singh B, Cangiarella JF.

Breast J. 2008 Jul-Aug;14(4):335-9. doi: 10.1111/j.1524-4741.2008.00594.x. Review.

PMID:
18537917
16.

The value of sentinel lymph node biopsy in ductal carcinoma in situ (DCIS) and DCIS with microinvasion of the breast.

van la Parra RF, Ernst MF, Barneveld PC, Broekman JM, Rutten MJ, Bosscha K.

Eur J Surg Oncol. 2008 Jun;34(6):631-5. Epub 2007 Sep 11.

PMID:
17851019
17.

Ductal carcinoma-in-situ: long-term results of breast-conserving therapy.

Mirza NQ, Vlastos G, Meric F, Sahin AA, Singletary SE, Newman LA, Kuerer HM, Ames FC, Ross MI, Feig BW, Pollock RE, Buchholz TA, McNeese MD, Strom EA, Hortobagyi GN, Hunt KK.

Ann Surg Oncol. 2000 Oct;7(9):656-64.

PMID:
11034242
18.

Factors predicting microinvasion in Ductal Carcinoma in situ.

Ozkan-Gurdal S, Cabioglu N, Ozcinar B, Muslumanoglu M, Ozmen V, Kecer M, Yavuz E, Igci A.

Asian Pac J Cancer Prev. 2014;15(1):55-60.

19.

The prediction of lymph node metastasis in ductal carcinoma in situ with microinvasion by assessing lymphangiogenesis.

Lee SK, Cho EY, Kim WW, Kim SH, Hur SM, Kim S, Choe JH, Kim JH, Kim JS, Lee JE, Nam SJ, Yang JH.

J Surg Oncol. 2010 Sep 1;102(3):225-9. doi: 10.1002/jso.21607.

PMID:
20740579
20.

Evaluation of vascular endothelial growth factor as a prognostic marker for local relapse in early-stage breast cancer patients treated with breast-conserving therapy.

Moran MS, Yang Q, Goyal S, Harris L, Chung G, Haffty BG.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1236-43. doi: 10.1016/j.ijrobp.2010.07.031. Epub 2010 Nov 17.

PMID:
21093162

Supplemental Content

Support Center